The use of vaccinia virus for the construction of recombinant vaccines

&
Bioessays 5 (6):248-252 (1986)
  Copy   BIBTEX

Abstract

Recombinant DNA technology has been used to engineer vaccinia virus genetically into a eukaryotic expression vector. An exciting outcome of these gene‐splicing techniques is that after the insertion of one or more genes which encode the information for antigens responsible for conferring immunity toward an infectious disease, vaccinia can be adapted for the development of live recombinant vaccines. This review discusses recombinant vaccinia design and the feasibility of using these vaccines for disease protection.

Categories

Keywords

Reprint years

DOI

10.1002/bies.950050604

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,665

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Uses of vaccinia virus as a vector for the production of live recombinant vaccines.Geoffrey L. Smith & Bernard Moss - 1984 - Bioessays 1 (3):120-124.
Jenner's Smallpox Vaccine: The Riddle of Vaccinia Virus and Its Origin by Derrick Baxby. [REVIEW]Ellen Smith - 1982 - Isis 73:586-586.
Recombinant DNA techniques in diagnostic and preventive medicine.Stephen Hodgkinson & Peter Scambler - 1984 - Bioessays 1 (1):12-15.
Synthesis and antiviral activity of 1-(n-substituted amino acetyl)-2-(5-substituted phthalimidomethyl) benzimidazoles.Archana Jyoti - 2020 - International Journal of Chemical Studies 8 (4):3227-3229.
Cancer, Viruses, and Mass Migration: Paul Berg’s Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967–1980. [REVIEW]Doogab Yi - 2008 - Journal of the History of Biology 41 (4):589 - 636.
Cancer, Viruses, and Mass Migration: Paul Berg’s Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967–1980.Doogab Yi - 2008 - Journal of the History of Biology 41 (4):589-636.
Gene analysis and its role in predicting susceptibility to disease.Steve Humphries & Nazzarena Barni - 1985 - Bioessays 3 (3):104-108.
Gene replacement therapy in the central nervous system: Viral vector-mediated therapy of global neurodegenerative disease.Edward A. Neuwelt, Michael A. Pagel, Alfred Geller & Leslie L. Muldoon - 1995 - Behavioral and Brain Sciences 18 (1):1-9.
Site‐specific mutagenesis of large DNA viral genomes.Frank J. Jenkins & Bernard Roizman - 1986 - Bioessays 5 (6):244-247.
The Development and Utilization of Recombinant DNA Technology.Sidney R. Kushner - 1978 - In John Richards (ed.), Recombinant DNA: science, ethics, and politics. New York: Academic Press. pp. 35--53.

Analytics

Added to PP
2013-11-23

Downloads
5 (#1,753,565)

6 months
2 (#1,693,267)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references